The retina of the eye contains photoreceptor cells that convert light into neuronal signals, which ultimately allow us to see. The mammalian retina has a very limited ability to regenerate, and damage ...

Diabetic retinopathy develops through complex microvascular damage driven by chronic hyperglycemia, yet traditional risk factors such as disease duration or glycemic control explain only part of ...

Previous studies have shown that amyloid accumulation in the retina mirrors similar deposits in the brain, suggesting the eye may reflect early disease processes. However, most clinical exams focus on ...

Please provide your email address to receive an email when new articles are posted on . Patients with inherited retinal diseases may present with seemingly routine conditions. Look for comorbid ...

More recently established treatments for RVO have taken a giant leap forward from laser photocoagulation since intravitreally ...

Recent studies hint that subtle shifts in the peripheral retina could flag Alzheimer’s disease years before brain damage or memory woes surface. This non-invasive eye window into neurodegeneration ...

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

Emerging research suggests early signs of Alzheimer’s disease may appear in the peripheral retina. Experts say Optical ...

A recent study published in the journal Npj Parkinson's Disease investigated whether increased thinning rate in the parafoveal ganglion cell-inner plexiform layer (pfGCIPL) and peripapillary retinal ...

Kiora Pharmaceuticals is narrowing its line of sight to only two assets that tackle rare retinal diseases, while two other programs will be handed off to prospective partners. The biotech is ...

The condition of the eye’s retina, and in particular the measure of retinal thickness (influenced by factors such as the amount of vascularization, atrophy, ischemic damage, and the presence or ...